Skip to main content
SpringerLink
Log in

Il glucagone spray nasale nel trattamento dell’ipoglicemia severa

  • FARMACI INNOVATIVI IN ENDOCRINOLOGIA
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Elliott L, Fidler C, Ditchfield A, Stissing T (2016) Hypoglycemia event rates: a comparison between real-world data and randomized controlled trial populations in insulin-treated diabetes. Diabetes Ther 7(1):45–60

    Article  CAS  Google Scholar 

  2. Giorda CB, Ozzello A, Gentile S et al. on behalf of the HYPOS-1 Study Group (2014) Incidence and correlates of hypoglycemia in type 2 diabetes. The Hypos-1 study. J Diabetes Metab 5:344

    Google Scholar 

  3. Agiostratidou G, Anhalt H, Ball D et al. (2017) Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, the Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care 40(12):1622–1630

    Article  Google Scholar 

  4. Pontiroli AE, Alberetto M, Pozza G (1985) Metabolic effects of intranasally administered glucagon: comparison with intramuscular and intravenous injection. Acta Diabetol Lat 22:103–110

    Article  CAS  Google Scholar 

  5. Rickels MR, Ruedy KJ, Foster NC et al. (2016) Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: a randomized crossover noninferiority study. Diabetes Care 39:264–270

    Article  CAS  Google Scholar 

  6. Porcellati F, Di Mauro S, Mazzieri A et al. (2021) Glucagon as a therapeutic approach to severe hypoglycemia: after 100 years, is it still the antidote of insulin? Biomolecules 9:1281

    Article  Google Scholar 

  7. Pontiroli AE, Tagliabue E (2020) Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: systematic review and meta-analysis. Acta Diabetol 57:743–749

    Article  Google Scholar 

  8. Settles JA, Gerety GF, Spaepen E et al. (2020) Nasal glucagon delivery is more successful than injectable delivery: a simulated severe hypoglycemia rescue. Endocr Pract 26(4):407–415

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Messina, Messina, Italia

    Annalisa Giandalia

  2. U.O.C. Diabetologia ed Endocrinologia, G.O.M. “Bianchi, Melacrino, Morelli”, Reggio Calabria, Italia

    Eugenio Alessi

Authors
  1. Annalisa Giandalia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eugenio Alessi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Annalisa Giandalia.

Ethics declarations

Conflitto di interesse

Annalisa Giandalia dichiara di aver ricevuto negli ultimi due anni compensi per l’attività di relatore e la partecipazione ad Advisory Boards da parte di NovoNordisk, Eli-Lilly, Daiichi Sankio. Eugenio Alessi dichiara di aver ricevuto negli ultimi due anni compensi per l’attività di relatore e la partecipazione ad Advisory Boards da parte di NovoNordisk, Eli-Lilly, Sanofi, Astrazeneca, Boehringher.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Gli autori di questo articolo non hanno eseguito studi sugli animali.

Additional information

Proposto da Rosaria M. Ruggeri.

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giandalia, A., Alessi, E. Il glucagone spray nasale nel trattamento dell’ipoglicemia severa. L'Endocrinologo 23, 317–319 (2022). https://doi.org/10.1007/s40619-022-01072-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-022-01072-x

Search

Navigation